Magnitude of increased infliximab clearance imposed by anti-infliximab antiobodies in Crohn's disease is determined by their concentration.

Helena Edlund; Casper Steenholdt; Mark Andrew Ainsworth; Eva Goebgen; Jørn Brynskov; Ole Østergaard Thomsen; Wilhelm Huisinga; Charlotte Kloft

Magnitude of increased infliximab clearance imposed by anti-infliximab antiobodies in Crohn's disease is determined by their concentration.

Helena Edlund, Casper Steenholdt, Mark Andrew Ainsworth, Eva Goebgen, Jørn Brynskov, Ole Østergaard Thomsen, Wilhelm Huisinga, Charlotte Kloft

Mave-, Tarm- og Leversygdomme

Originalsprog	Engelsk
Tidsskrift	AAPS Journal
Sider (fra-til)	223-233
Antal sider	10
ISSN	1550-7416
Status	Udgivet - 2017

Citationsformater

@article{b195f3280e9f46da9ec6bd254553ce4a,

title = "Magnitude of increased infliximab clearance imposed by anti-infliximab antiobodies in Crohn's disease is determined by their concentration.",

author = "Helena Edlund and Casper Steenholdt and Ainsworth, {Mark Andrew} and Eva Goebgen and J{\o}rn Brynskov and Thomsen, {Ole {\O}stergaard} and Wilhelm Huisinga and Charlotte Kloft",

year = "2017",

language = "English",

pages = "223--233",

journal = "AAPS Journal",

issn = "1550-7416",

publisher = "Springer New York LLC",

}

TY - JOUR

T1 - Magnitude of increased infliximab clearance imposed by anti-infliximab antiobodies in Crohn's disease is determined by their concentration.

AU - Edlund, Helena

AU - Steenholdt, Casper

AU - Ainsworth, Mark Andrew

AU - Goebgen, Eva

AU - Brynskov, Jørn

AU - Thomsen, Ole Østergaard

AU - Huisinga, Wilhelm

AU - Kloft, Charlotte

PY - 2017

Y1 - 2017

M3 - Journal article

SN - 1550-7416

SP - 223

EP - 233

JO - AAPS Journal

JF - AAPS Journal

ER -